Clin2
NCT06532370Possibly a fitRecruiting

Reward program for methamphetamine use after trauma in Hawaii

Contingency ManagmentMethamphetamine Use Disorder

Part of Mental health clinical trials.

This study tests a program that uses rewards (like gift cards) to encourage people who use methamphetamine and have been hospitalized for a trauma to stop using. The program is designed for people in Hawaii and aims to help them reduce or quit methamphetamine use.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You were admitted to the hospital for a traumatic injury (like a car crash or fall).
  • Your urine test for methamphetamine came back positive during this hospital stay.
  • You have been using methamphetamine at least once a week.
  • You first used methamphetamine more than 6 months before your injury.
  • You have at least 4 symptoms of moderate to severe methamphetamine use disorder (e.g., cravings, withdrawal, trouble controlling use).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06931197Not yet recruiting
Start treatment for methamphetamine use after a traumatic injury

This study tests whether starting a reward-based treatment program while you are still in the hospital can help reduce methamphetamine use after a traumatic injury. You may be able to join if you test positive for methamphetamine, use it at least weekly, and have moderate or severe trouble controlling your use.

Honolulu, Hawaii
NCT07211724Not yet recruiting
Heart failure support for people with methamphetamine use

This study tests a support program for people with heart failure who also use methamphetamine and want to quit. It aims to improve both heart health and recovery from substance use.

Los Angeles, California
NCT07226596Recruiting
Methamphetamine use: can you reduce without quitting?

This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.

Lexington, Kentucky
NCT07774702Not yet recruiting· Phase 2
Psilocybin for methamphetamine use disorder

This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.

Birmingham, Alabama
NCT06899594Recruiting· Early Phase 1
Psilocybin for quitting methamphetamine

This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.

Shreveport, Louisiana
NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York

Hear when a new Methamphetamine Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.